SOTERINIM Trademark

Trademark Overview

On Thursday, August 25, 2016, a trademark application was filed for SOTERINIM with the United States Patent and Trademark Office. The USPTO has given the SOTERINIM trademark a serial number of 87150711. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 27, 2020. This trademark is owned by Pfizer Inc,. The SOTERINIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
soterinim

General Information

Serial Number87150711
Word MarkSOTERINIM
Filing DateThursday, August 25, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc,
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc,
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, July 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 30, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 30, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019EXTENSION 5 GRANTED
Friday, December 6, 2019EXTENSION 5 FILED
Friday, December 6, 2019TEAS EXTENSION RECEIVED
Tuesday, December 3, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 3, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, May 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2019EXTENSION 4 GRANTED
Thursday, May 16, 2019EXTENSION 4 FILED
Thursday, May 16, 2019TEAS EXTENSION RECEIVED
Friday, December 7, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 5, 2018EXTENSION 3 GRANTED
Wednesday, December 5, 2018EXTENSION 3 FILED
Wednesday, December 5, 2018TEAS EXTENSION RECEIVED
Saturday, May 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 10, 2018EXTENSION 2 GRANTED
Thursday, May 10, 2018EXTENSION 2 FILED
Thursday, May 10, 2018TEAS EXTENSION RECEIVED
Tuesday, December 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 11, 2017EXTENSION 1 GRANTED
Tuesday, December 5, 2017EXTENSION 1 FILED
Friday, December 8, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 5, 2017TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 17, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, February 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 20, 2017ASSIGNED TO LIE
Wednesday, February 8, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 6, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 6, 2016NON-FINAL ACTION E-MAILED
Tuesday, December 6, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2016ASSIGNED TO EXAMINER
Wednesday, August 31, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 29, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

soterinim preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases